Skip to main content
. 2017 Jun 14;12:1731–1740. doi: 10.2147/COPD.S121723

Figure 2.

Figure 2

Symptomatic patients: mean changes from baseline in FEV1 at week 6 over 24 hours.

Notes: Placebo N=60, aclidinium 400 μg N=116, tiotropium 18 μg N=101. *P<0.05 versus tiotropium; P<0.05 for aclidinium 400 μg versus placebo and tiotropium 18 μg versus placebo at all time points, except aclidinium at 10 hours (P=0.08) and tiotropium at 23 hours (P=0.14).

Abbreviations: FEV1, forced expiratory volume in 1 second; LS, least squares.